Table 1 Clinical characteristics and bleeding outcomes in Chinese patients with ACS
Characteristics | Total cohort | Bleeding | Non-bleeding | P |
|---|---|---|---|---|
n = 563 | n = 37 | n = 526 | ||
Age (Years) | 62.98 ± 11.49 | 59.38 ± 11.95 | 63.24 ± 11.42 | 0.048 |
Sex (Male)—No. (%) | 413 (73.4) | 32 (86.5) | 381 (72.4) | 0.082 |
Risk factors—No. (%) | ||||
Familial history of CAD | 107 (19.0) | 10 (27.0) | 97 (18.4) | 0.197 |
Active cigarette smoking | 279 (49.6) | 20(54.1) | 259 (49.2) | 0.613 |
Arterial hypertension | 401 (71.2) | 22 (59.5) | 379 (72.1) | 0.131 |
Hyperlipidemia | 302 (53.6) | 17 (45.9) | 285 (54.2) | 0.395 |
Diabetes mellitus | 183 (32.5) | 13 (35.1) | 170 (32.3) | 0.856 |
Drug therapy—No. (%) | ||||
Statin | 537 (95.4) | 36 (97.3) | 501 (95.2) | 1 |
β-Receptor blocker | 446 (82.8) | 27 (73.0) | 439 (83.5) | 0.115 |
ACEI/ARB | 354 (62.9) | 11 (29.7) | 343 (65.2) | < 0.001 |
CCB | 250 (44.4) | 13 (35.1) | 237 (45.1) | 0.350 |
PPI | 68 (12.1) | 8 (21.6) | 60 (11.4) | 0.071 |
Aspirin | 547 (97.2) | 36 (97.3) | 511 (97.1) | 1 |